$CADL is leading the Prism MarketView Pharmaceuticals index, today Citi began coverage on them, assigning a Buy rating and setting a price target of $25.00….
February 20, 2025
February 19, 2025
Allurion Technologies Inc.
February 19, 2025
21 Vianet Group Inc.
February 18, 2025
GeneDx Holdings Corp.
February 14, 2025
SoundHound AI Inc.
February 14, 2025
OS Therapies Inc.
February 13, 2025
Moleculin Biotech, Inc.
February 13, 2025
Innodata Inc.
February 12, 2025
Kala Pharmaceuticals, Inc.
February 12, 2025
Upstart Holdings Inc.
February 12, 2025
Lightbridge Corp.
February 11, 2025





